1006 related articles for article (PubMed ID: 33953641)
1. From the Role of Microbiota in Gut-Lung Axis to SARS-CoV-2 Pathogenesis.
Ahmadi Badi S; Tarashi S; Fateh A; Rohani P; Masotti A; Siadat SD
Mediators Inflamm; 2021; 2021():6611222. PubMed ID: 33953641
[TBL] [Abstract][Full Text] [Related]
2. Microbiota Modulation of the Gut-Lung Axis in COVID-19.
de Oliveira GLV; Oliveira CNS; Pinzan CF; de Salis LVV; Cardoso CRB
Front Immunol; 2021; 12():635471. PubMed ID: 33717181
[TBL] [Abstract][Full Text] [Related]
3. Alteration of the gut microbiota following SARS-CoV-2 infection correlates with disease severity in hamsters.
Sencio V; Machelart A; Robil C; Benech N; Hoffmann E; Galbert C; Deryuter L; Heumel S; Hantute-Ghesquier A; Flourens A; Brodin P; Infanti F; Richard V; Dubuisson J; Grangette C; Sulpice T; Wolowczuk I; Pinet F; Prévot V; Belouzard S; Briand F; Duterque-Coquillaud M; Sokol H; Trottein F
Gut Microbes; 2022; 14(1):2018900. PubMed ID: 34965194
[TBL] [Abstract][Full Text] [Related]
4. Roles of the gut microbiota in severe SARS-CoV-2 infection.
Liu Y; Kuang D; Li D; Yang J; Yan J; Xia Y; Zhang F; Cao H
Cytokine Growth Factor Rev; 2022 Feb; 63():98-107. PubMed ID: 35131164
[TBL] [Abstract][Full Text] [Related]
5. Cross-talk between immune system and microbiota in COVID-19.
Baradaran Ghavami S; Pourhamzeh M; Farmani M; Raftar SKA; Shahrokh S; Shpichka A; Asadzadeh Aghdaei H; Hakemi-Vala M; Hossein-Khannazer N; Timashev P; Vosough M
Expert Rev Gastroenterol Hepatol; 2021 Nov; 15(11):1281-1294. PubMed ID: 34654347
[TBL] [Abstract][Full Text] [Related]
6. Gut microbiota in COVID-19: key microbial changes, potential mechanisms and clinical applications.
Zhang F; Lau RI; Liu Q; Su Q; Chan FKL; Ng SC
Nat Rev Gastroenterol Hepatol; 2023 May; 20(5):323-337. PubMed ID: 36271144
[TBL] [Abstract][Full Text] [Related]
7. Probiotics in Treatment of Viral Respiratory Infections and Neuroinflammatory Disorders.
Shahbazi R; Yasavoli-Sharahi H; Alsadi N; Ismail N; Matar C
Molecules; 2020 Oct; 25(21):. PubMed ID: 33105830
[TBL] [Abstract][Full Text] [Related]
8. Considerations for Gut Microbiota and Probiotics in Patients with Diabetes Amidst the Covid-19 Pandemic: A Narrative Review.
Barengolts E; Smith ED
Endocr Pract; 2020 Oct; 26(10):1186-1195. PubMed ID: 33471720
[TBL] [Abstract][Full Text] [Related]
9. The Role of Bacterial and Fungal Human Respiratory Microbiota in COVID-19 Patients.
Soltani S; Zakeri A; Zandi M; Kesheh MM; Tabibzadeh A; Dastranj M; Faramarzi S; Didehdar M; Hafezi H; Hosseini P; Farahani A
Biomed Res Int; 2021; 2021():6670798. PubMed ID: 33681368
[TBL] [Abstract][Full Text] [Related]
10. Gut microbiota and Covid-19- possible link and implications.
Dhar D; Mohanty A
Virus Res; 2020 Aug; 285():198018. PubMed ID: 32430279
[TBL] [Abstract][Full Text] [Related]
11. SARS-CoV-2 infection in nonhuman primates alters the composition and functional activity of the gut microbiota.
Sokol H; Contreras V; Maisonnasse P; Desmons A; Delache B; Sencio V; Machelart A; Brisebarre A; Humbert L; Deryuter L; Gauliard E; Heumel S; Rainteau D; Dereuddre-Bosquet N; Menu E; Ho Tsong Fang R; Lamaziere A; Brot L; Wahl C; Oeuvray C; Rolhion N; Van Der Werf S; Ferreira S; Le Grand R; Trottein F
Gut Microbes; 2021; 13(1):1-19. PubMed ID: 33685349
[TBL] [Abstract][Full Text] [Related]
12. Main Clinical Features of COVID-19 and Potential Prognostic and Therapeutic Value of the Microbiota in SARS-CoV-2 Infections.
He Y; Wang J; Li F; Shi Y
Front Microbiol; 2020; 11():1302. PubMed ID: 32582134
[TBL] [Abstract][Full Text] [Related]
13. Alterations of the gut microbiota in coronavirus disease 2019 and its therapeutic potential.
Xiang H; Liu QP
World J Gastroenterol; 2022 Dec; 28(47):6689-6701. PubMed ID: 36620345
[TBL] [Abstract][Full Text] [Related]
14. Probiotics in Medicine: A Long Debate.
Stavropoulou E; Bezirtzoglou E
Front Immunol; 2020; 11():2192. PubMed ID: 33072084
[TBL] [Abstract][Full Text] [Related]
15. Diet, Probiotics and Their Impact on the Gut Microbiota during the COVID-19 Pandemic.
Jabczyk M; Nowak J; Hudzik B; Zubelewicz-Szkodzińska B
Nutrients; 2021 Sep; 13(9):. PubMed ID: 34579048
[TBL] [Abstract][Full Text] [Related]
16. Neuropsychiatric Ramifications of COVID-19: Short-Chain Fatty Acid Deficiency and Disturbance of Microbiota-Gut-Brain Axis Signaling.
Sajdel-Sulkowska EM
Biomed Res Int; 2021; 2021():7880448. PubMed ID: 34651049
[TBL] [Abstract][Full Text] [Related]
17. Gut microbiome, Vitamin D, ACE2 interactions are critical factors in immune-senescence and inflammaging: key for vaccine response and severity of COVID-19 infection.
Shenoy S
Inflamm Res; 2022 Jan; 71(1):13-26. PubMed ID: 34738147
[TBL] [Abstract][Full Text] [Related]
18. Targeting the gut-lung microbiota axis by means of a high-fibre diet and probiotics may have anti-inflammatory effects in COVID-19 infection.
Conte L; Toraldo DM
Ther Adv Respir Dis; 2020; 14():1753466620937170. PubMed ID: 32600125
[TBL] [Abstract][Full Text] [Related]
19. Premises among SARS-CoV-2, dysbiosis and diarrhea: Walking through the ACE2/mTOR/autophagy route.
de Oliveira AP; Lopes ALF; Pacheco G; de Sá Guimarães Nolêto IR; Nicolau LAD; Medeiros JVR
Med Hypotheses; 2020 Nov; 144():110243. PubMed ID: 33254549
[TBL] [Abstract][Full Text] [Related]
20. Probiotics, Photobiomodulation, and Disease Management: Controversies and Challenges.
Ailioaie LM; Litscher G
Int J Mol Sci; 2021 May; 22(9):. PubMed ID: 34066560
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
